Two Sigma Investments

Two Sigma Investments’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Two Sigma Investments’s Portfolio KNTE Stock Details KNTE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$710K	Buy
2023 Q3	$192K	Buy
2023 Q2	$344K	Buy
2022 Q4	–	Sell
2022 Q3	$123K	Buy
2022 Q2	–	Sell
2022 Q1	$259K	Buy
2021 Q4	–	Sell
2021 Q3	$206K	Buy